Lv3
370 积分 2023-08-30 加入
Exploring functional insights into the human gut microbiome via the structural proteome
3个月前
已完结
Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial
5个月前
已完结
Immunotherapies for hepatocellular carcinoma
5个月前
已完结
皖公网安备34019202002308
